Cited by 625Cell death mechanisms and regulationCancer-related Molecular PathwaysAutophagy in Disease and Therapy

The DOI matches its Crossref record; 182 of the 185 references it cites were found in a registry or an index.

The BCL2 Family: Key Mediators of the Apoptotic Response to Targeted Anticancer Therapeutics

Open access

Hata, Aaron N., Engelman, Jeffrey A., Faber, Anthony C.·2015·Cancer Discovery

DOI 10.1158/2159-8290.cd-15-0011PMC PMC4727530

Open this paper in CoChat — free account

Abstract

The ability of cancer cells to suppress apoptosis is critical for carcinogenesis. The BCL2 family proteins comprise the sentinel network that regulates the mitochondrial or intrinsic apoptotic response. Recent advances in our understanding of apoptotic signaling pathways have enabled methods to identify cancers that are “primed” to undergo apoptosis, and have revealed potential biomarkers that may predict which cancers will undergo apoptosis in response to specific therapies. Complementary efforts have focused on developing novel drugs that directly target antiapoptotic BCL2 family proteins. In this review, we summarize the current knowledge of the role of BCL2 family members in cancer development and response to therapy, focusing on targeted therapeutics, recent progress in the development of apoptotic biomarkers, and therapeutic strategies designed to overcome deficiencies in apoptosis. Significance: Apoptosis, long known to be important for response to conventional cytotoxic chemotherapy, has more recently been shown to be essential for the efficacy of targeted therapies. Approaches that increase the likelihood of a cancer to undergo apoptosis following therapy may help improve targeted treatment strategies. Cancer Discov; 5(5); 475–87. ©2015 AACR.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1158/2159-8290.cd-15-0011

Cites

182 of 182 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Activating Mutations in the Epidermal Growth Factor Receptor Underlying Responsiveness of Non–Small-Cell Lung Cancer to Gefitinib
Lynch, T. J., Bell, D. W., Sordella, R., Gurubhagavatula, S., Okimoto, R. A., Brannigan, B. W., Harris, P. L., Haserlat, S. M., Supko, J. G., Haluska, F. G., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040938 · Cited by 11,486
EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy
Paez, J. G., Jänne, P. A., Lee, J. C., Tracy, S., Greulich, H., Gabriel, S., Herman, P., Kaye, F. J., Lindeman, N., Boggon, T. J., et al. (2004) · Science · doi:10.1126/science.1099314 · Cited by 9,368
Gefitinib or Carboplatin–Paclitaxel in Pulmonary Adenocarcinoma
Mok, T. S., Wu, Y.-L., Thongprasert, S., Yang, C.-H., Chu, D.-T., Saijo, N., Sunpaweravong, P., Han, B., Margono, B., Ichinose, Y., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0810699 · Cited by 8,261
Improved survival with vemurafenib in melanoma with BRAF V600E mutation
Chapman, P. B., Hauschild, A., Robert, C., Haanen, J. B., Ascierto, P., Larkin, J., Dummer, R., Garbe, C., Testori, A., Maio, M., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1103782 · Cited by 7,720
Akt phosphorylation of BAD couples survival signals to the cell-intrinsic death machinery
Datta, S. R., Dudek, H., Tao, X., Masters, S., Fu, H., Gotoh, Y., & Greenberg, M. E. (1997) · Cell · doi:10.1016/s0092-8674(00)80405-5 · Cited by 5,689
Gefitinib or Chemotherapy for Non–Small-Cell Lung Cancer with Mutated EGFR
Maemondo, M., Inoue, A., Kobayashi, K., Sugawara, S., Oizumi, S., Isobe, H., Gemma, A., Harada, M., Yoshizawa, H., Kinoshita, I., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0909530 · Cited by 5,525
Erlotinib versus standard chemotherapy as first-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial
Rosell, R., Carcereny, E., Gervais, R., Vergnenegre, A., Massuti, B., Felip, E., Palmero, R., Garcia-Gomez, R., Pallares, C., Sanchez, J. M., et al. (2012) · The Lancet Oncology · doi:10.1016/s1470-2045(11)70393-x · Cited by 5,489
Cell Death
Danial, N. N., & Korsmeyer, S. J. (2004) · Cell · doi:10.1016/s0092-8674(04)00046-7 · Cited by 4,651
Anaplastic Lymphoma Kinase Inhibition in Non–Small-Cell Lung Cancer
Kwak, E. L., Bang, Y., Camidge, D. R., Shaw, A. T., Solomon, B., Maki, R. G., Ou, S. I., Dezube, B. J., Janne, P. A., Costa, D. B., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa1006448 · Cited by 4,477
Self-citation

Show all 185 references

Sorted by citations

Items 201–300 of 625

RETRACTED: Lycorine Displays Potent Antitumor Efficacy in Colon Carcinoma by Targeting STAT3
Wu, S., Qiu, Y., Shao, Y., Yin, S., Wang, R. Y., Pang, X., Ma, J., Zhang, C., Wu, B., Koo, S., et al. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00881 · Cited by 32
Retracted
DNAi-peptide nanohybrid smart particles target BCL-2 oncogene and induce apoptosis in breast cancer cells
Alipour, M. A., Sheikhnejad, R. G., Fouani, M. H., Bardania, H., & Hosseinkhani, S. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115299 · Cited by 31
Bacteria‐Mediated Tumor‐Targeting Delivery of Multienzyme‐Mimicking Covalent Organic Frameworks Promoting Pyroptosis for Combinatorial Sono‐Catalytic Immunotherapy
Liu, Y., Xiang, L., Li, Y., Zhang, S., Zhang, Y., Shi, H. R., Liu, H., Du, D., Zhou, B., Ye, B., et al. (2024) · Advanced Science · doi:10.1002/advs.202407133 · Cited by 34
NF-κB signaling and the tumor microenvironment in osteosarcoma: implications for immune evasion and therapeutic resistance
Shi, S., Ou, X., Liu, C., Li, R., Zheng, Q., & Hu, L. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1518664 · Cited by 37
Targeted therapy with a selective BCL-2 inhibitor in older patients with acute myeloid leukemia
Campos, E. D. V., & Pinto, R. (2018) · Hematology Transfusion and Cell Therapy · doi:10.1016/j.htct.2018.09.001 · Cited by 31
Macroporous organosilicon nanocomposites co-deliver Bcl2-converting peptide and chemotherapeutic agent for synergistic treatment against multidrug resistant cancer
Xie, J., Xu, W., Wu, Y., Niu, B., & Zhang, X.-K. (2019) · Cancer Letters · doi:10.1016/j.canlet.2019.10.018 · Cited by 31
The insect molting hormone 20-hydroxyecdysone protects dopaminergic neurons against MPTP-induced neurotoxicity in a mouse model of Parkinson’s disease
Lim, H.-S., Moon, B. C., Lee, J., Choi, G., & Park, G. (2020) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2020.07.010 · Cited by 30
Pazopanib and Trametinib as a Synergistic Strategy against Osteosarcoma: Preclinical Activity and Molecular Insights
Chiabotto, G., Grignani, G., Todorovic, M., Martín, V., Centomo, M. L., Prola, E., Giordano, G. D., Merlini, A., Miglio, U., Berrino, E., et al. (2020) · Cancers · doi:10.3390/cancers12061519 · Cited by 30
Cellular and Molecular Mechanisms of Pristimerin in Cancer Therapy: Recent Advances
Chen, R., Yang, F., Zhang, M., Sun, Z., & Zhang, N. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.671548 · Cited by 29
Surface marker profiling of SH-SY5Y cells enables small molecule screens identifying BMP4 as a modulator of neuroblastoma differentiation
Ferlemann, F. C., Menon, V., Condurat, A. L., Rössler, J. K., & Pruszak, J. (2017) · Scientific Reports · doi:10.1038/s41598-017-13497-8 · Cited by 30
A novel polysaccharide from the Sarcodon aspratus triggers apoptosis in Hela cells via induction of mitochondrial dysfunction
Wang, D., Wu, Q.-X., Pan, W., Hussain, S., Mehmood, S., & Chen, Y. (2018) · Food & Nutrition Research · doi:10.29219/fnr.v62.1285 · Cited by 30
Coamplification of miR-4728 protects HER2 -amplified breast cancers from targeted therapy
Floros, K. V., Lochmann, T. L., Hu, B., Monterrubio, C., Hughes, M. T., Wells, J. D., Morales, C. B., Ghotra, M. S., Costa, C., Souers, A. J., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1717820115 · Cited by 30
Self-citation
Pyrimethamine conjugated histone deacetylase inhibitors: Design, synthesis and evidence for triple negative breast cancer selective cytotoxicity
Wu, B., Fathi, S., Mortley, S., Mohiuddin, M., Jang, Y. C., & Oyelere, A. K. (2020) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2020.115345 · Cited by 30
Blockage of the mevalonate pathway overcomes the apoptotic resistance to MEK inhibitors with suppressing the activation of Akt in cancer cells
Iizuka-Ohashi, M., Watanabe, M., Sukeno, M., Morita, M., Hoang, N. T. H., Kuchimaru, T., Kizaka‐Kondoh, S., Sowa, Y., Sakaguchi, K., Taguchi, T., et al. (2018) · Oncotarget · doi:10.18632/oncotarget.24696 · Cited by 29
Development of 2-oxindolin-3-ylidene-indole-3-carbohydrazide derivatives as novel apoptotic and anti-proliferative agents towards colorectal cancer cells
Eldehna, W. M., Abo-Ashour, M. F., Al-Warhi, T. I., Al‐Rashood, S. T., Alharbi, A., Ayyad, R. R. A., Al‐Khayal, K., Abdulla, M., Abdel‐Aziz, H. A., Ahmad, R., et al. (2020) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.1080/14756366.2020.1862100 · Cited by 29
The Impact of lncRNAs and miRNAs on Apoptosis in Lung Cancer
Ghafouri‐Fard, S., Aghabalazade, A., Shoorei, H., Majidpoor, J., Taheri, M. N., & Mokhtari, M. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.714795 · Cited by 28
Notch2 suppression mimicking changes in human pulmonary hypertension modulates Notch1 and promotes endothelial cell proliferation
Sahoo, S., Li, Y., de Jesus, D. S., Sembrat, J., Rojas, M. M., Goncharova, E. A., Cifuentes-Pagano, E., Straub, A. C., & Pagano, P. J. (2021) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00125.2021 · Cited by 30
Anticancer Activities of Biogenic Silver Nanoparticles Targeting Apoptosis and Inflammatory Pathways in Colon Cancer Cells
Narasimha, V. R., Latha, T. S., Reddanna, P., Panati, K., & Narala, V. R. (2021) · Journal of Cluster Science · doi:10.1007/s10876-021-02143-z · Cited by 29
Reactive oxygen species-dependent apoptosis induction by water extract of Citrus unshiu peel in MDA-MB-231 human breast carcinoma cells
Kim, M. Y., Choi, E. O., Hwangbo, H., Kwon, D. H., Ahn, K. I., Kim, H. J., Ji, S. Y., Hong, S. H., Jeong, J., Kim, G., et al. (2018) · Nutrition Research and Practice · doi:10.4162/nrp.2018.12.2.129 · Cited by 30
Spatial targeting of Bcl-2 on endoplasmic reticulum and mitochondria in cancer cells by lipid nanoparticles
Pandey, S., Patil, S., Ballav, N., & Basu, S. (2020) · Journal of Materials Chemistry B · doi:10.1039/d0tb00408a · Cited by 26
Ginsenoside panaxatriol reverses TNBC paclitaxel resistance by inhibiting the IRAK1/NF-κB and ERK pathways
Wang, P., Song, D., Wan, D., Li, L., Mei, W., Li, X., Li, H., Zhu, X., Yang, L., Cai, Y., et al. (2020) · PeerJ · doi:10.7717/peerj.9281 · Cited by 28
Nisin induces apoptosis in cervical cancer cells via reactive oxygen species generation and mitochondrial membrane potential changes
Sadri, H., Aghaei, M., & Akbari, V. (2022) · Biochemistry and Cell Biology · doi:10.1139/bcb-2021-0225 · Cited by 28
Activation of the integrated stress response is a vulnerability for multidrug‐resistant FBXW7‐deficient cells
Sanchez‐Burgos, L., Navarro‐González, B., García‐Martín, S., Sirozh, O., Mota‐Pino, J., Fueyo‐Marcos, E., Tejero, H., Antón, M. E., Murga, M., Al‐Shahrour, F., et al. (2022) · EMBO Molecular Medicine · doi:10.15252/emmm.202215855 · Cited by 27
miR-509-3p Promotes Cisplatin-Induced Apoptosis in Ovarian Cancer Cells Through the Regulation of Anti-Apoptotic Genes
Chen, W., Du, J., Li, X., Su, J., Huang, Y., Ding, N., Zhang, M., & Jiang, S. (2017) · Pharmacogenomics · doi:10.2217/pgs-2017-0115 · Cited by 27
Apoptosis induced by bruceine�D in human non‑small‑cell lung cancer cells involves mitochondrial ROS‑mediated death signaling
Xie, J., Lai, Z., Zheng, X., Xian, Y., Li, Q., Ip, S., Xie, Y., Chen, J., Su, Z., Lin, Z., et al. (2019) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2019.4363 · Cited by 27
Nuclear Export Inhibitors Selinexor (KPT-330) and Eltanexor (KPT-8602) Provide a Novel Therapy to Reduce Tumor Growth by Induction of PANoptosis
Camilli, S., Lockey, R. F., & Kolliputi, N. (2023) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-023-01135-2 · Cited by 29
(±)-Gossypol induces apoptosis and autophagy in head and neck carcinoma cell lines and inhibits the growth of transplanted salivary gland cancer cells in BALB/ c mice
Benvenuto, M., Mattera, R., Masuelli, L., Taffera, G., Andracchio, O., Tresoldi, I., Lido, P., Giganti, M. G., Godos, J., Modesti, A., et al. (2016) · International Journal of Food Sciences and Nutrition · doi:10.1080/09637486.2016.1236077 · Cited by 27
Proanthocyanidin Polymer-Rich Fraction of Stryphnodendron adstringens Promotes in Vitro and in Vivo Cancer Cell Death via Oxidative Stress
Kaplum, V., Ramos, A. C., Consolaro, M. E. L., Fernandez, M. A., Ueda‐Nakamura, T., Filho, B. P. D., Silva, S. D. O., de Mello, J. C. P., & Nakamura, C. V. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00694 · Cited by 27
Diverse actions of sirtuin-1 on ovulatory genes and cell death pathways in human granulosa cells
Sapuleni, J., Szymańska, M., & Meidan, R. (2022) · Reproductive Biology and Endocrinology · doi:10.1186/s12958-022-00970-x · Cited by 27
Synthetic Lethal Interaction with BCL-XL Blockade Deepens Response to Cetuximab in Patient-Derived Models of Metastatic Colorectal Cancer
Leto, S. M., Ferri, M., Sassi, F. P., Zanella, E. R., Cottino, F., Vurchio, V., Catalano, I., Ferrero, A., Zingaretti, C. C., Marchiò, C., et al. (2023) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-22-2550 · Cited by 28
Antitumor effect of exopolysaccharide from Lactiplantibacillus plantarum WLPL09 on melanoma mice via regulating immunity and gut microbiota
Wang, Q., Jiang, B., Wei, M., He, Y., Wang, Y., Zhang, Q., Wei, H., & Tao, X. (2023) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2023.127624 · Cited by 26
Prolyl isomerase Pin1 promotes survival in EGFR-mutant lung adenocarcinoma cells with an epithelial–mesenchymal transition phenotype
Sakuma, Y., Nishikiori, H., Hirai, S., Yamaguchi, M., Yamada, G., Watanabe, A., Hasegawa, T., Kojima, T., Niki, T., & Takahashi, H. (2016) · Laboratory Investigation · doi:10.1038/labinvest.2015.155 · Cited by 26
Mitochondrial matrix chaperone and c-myc inhibition causes enhanced lethality in glioblastoma
Ishida, C. T., Shu, C., Halatsch, M., Westhoff, M., Altieri, D. C., Karpel‐Massler, G., & Siegelin, M. D. (2017) · Oncotarget · doi:10.18632/oncotarget.16202 · Cited by 26
Bax retrotranslocation potentiates Bcl-xL’s antiapoptotic activity and is essential for switch-like transitions between MOMP competency and resistance
Hantusch, A., Das, K. K., García‐Sáez, A. J., Brunner, T., & Rehm, M. (2018) · Cell Death and Disease · doi:10.1038/s41419-018-0464-6 · Cited by 27
Pachymic Acid Sensitizes Gastric Cancer Cells to Radiation Therapy by UpregulatingBaxthrough Hypoxia
Lu, C., Cai, D., & Ma, J. (2018) · The American Journal of Chinese Medicine · doi:10.1142/s0192415x18500465 · Cited by 26
Apoptotic role of marine sponge symbiont Bacillus subtilis NMK17 through the activation of caspase-3 in human breast cancer cell line
Natesh, N. S., Arumugam, M. K., & Karanam, G. (2018) · Molecular Biology Reports · doi:10.1007/s11033-018-4434-y · Cited by 26
The Basic Research of the Combinatorial Therapy of ABT-199 and Homoharringtonine on Acute Myeloid Leukemia
Shi, Y., Ye, J., Yang, Y., Zhao, Y., Shen, H., Ye, X., & Xie, W. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.692497 · Cited by 25
Targeting BCL2 with venetoclax is a promising therapeutic strategy for “double-proteinexpression” lymphoma with MYC and BCL2 rearrangements
Uchida, A., Isobe, Y., Asano, J., Uemura, Y., Hoshikawa, M., Takagi, M., & Miura, I. (2018) · Haematologica · doi:10.3324/haematol.2018.204958 · Cited by 26
Antiproliferative activity and apoptosis induction by trijuganone C isolated from the root of Salvia miltiorrhiza Bunge (Danshen)
Uto, T., Tùng, N. H., Ohta, T., Juengsanguanpornsuk, W., Hung, L. Q., Hải, N. T., Long, D. D., Thương, P. T., Okubo, S., Hirata, S., et al. (2018) · Phytotherapy Research · doi:10.1002/ptr.6013 · Cited by 25
Organ transcriptomes of the lucinid clam Loripes orbiculatus (Poli, 1791) provide insights into their specialised roles in the biology of a chemosymbiotic bivalve
Yuen, B., Polzin, J., & Petersen, J. M. (2019) · BMC Genomics · doi:10.1186/s12864-019-6177-0 · Cited by 25
Overcoming MCL-1-driven adaptive resistance to targeted therapies
Wood, K. C. (2020) · Nature Communications · doi:10.1038/s41467-020-14392-z · Cited by 25
Strategic Combinations to Prevent and Overcome Resistance to Targeted Therapies in Oncology
Gümüşay, Ö., Vitiello, P. P., Wabl, C. A., Corcoran, R. B., Bardelli, A., & Rugo, H. S. (2020) · American Society of Clinical Oncology Educational Book · doi:10.1200/edbk_280845 · Cited by 29
Black tea and curcumin synergistically mitigate the hepatotoxicity and nephropathic changes induced by chronic exposure to aflatoxin‐B1 in Sprague–Dawley rats
El-Mekkawy, H. I., Al-Kahtani, M. A., Shati, A. A., AlShehri, M. A., Al-Doaiss, A. A., El‐Mansi, A. A., & Ahmed, A. E. (2020) · Journal of Food Biochemistry · doi:10.1111/jfbc.13346 · Cited by 25
Chidamide and apatinib are therapeutically synergistic in acute myeloid leukemia stem and progenitor cells
Zhao, H., Jiang, Y., Lin, F., Zhong, M., Tan, J., Zhou, Y., Liu, L., Li, G., Deng, M., & Xu, B. (2022) · Experimental Hematology and Oncology · doi:10.1186/s40164-022-00282-1 · Cited by 25
Design, synthesis, molecular modeling and biological evaluation of novel Benzoxazole-Benzamide conjugates via a 2-Thioacetamido linker as potential anti-proliferative agents, VEGFR-2 inhibitors and apoptotic inducers
Eissa, I. H., El-Haggar, R. S., Dahab, M. A., Ahmed, M. F. E., Mahdy, H. A., Alsantali, R. I., Elwan, A., Masurier, N., & Fatahala, S. S. (2022) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.1080/14756366.2022.2081844 · Cited by 25
Targeting endoplasmic reticulum stress using natural products in neurological disorders
Jangra, A., Verma, M., Kumar, D., Chandrika, Rachamalla, M., Dey, A., Dua, K., Jha, S. K., Ojha, S. K., Alexiou, A. T., et al. (2022) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2022.104818 · Cited by 25
Discovery of aliphatic-chain hydroxamates containing indole derivatives with potent class I histone deacetylase inhibitory activities
Chao, S.-W., Chen, L., Yu, C.-C., Liu, C., Lin, T. E., Guh, J., Wang, C.-Y., Chen, C.-Y., Hsu, K., & Huang, W. (2017) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2017.11.092 · Cited by 25
Structure–Activity Relationships and Molecular Docking Analysis of Mcl-1 Targeting Renieramycin T Analogues in Patient-derived Lung Cancer Cells
Petsri, K., Yokoya, M., Tungsukruthai, S., Rungrotmongkol, T., Nutho, B., Vinayanuwattikun, C., Saito, N., Matsubara, T., Sato, R., & Pithi Chanvorachote, B. (2020) · Cancers · doi:10.3390/cancers12040875 · Cited by 26
The role of Se content in improving anti-tumor activities and its potential mechanism for selenized Artemisia sphaerocephala polysaccharides
Liu, S., Hu, J., Li, M., Zhu, S., Guo, S., Guo, H., Wang, T., Zhang, Y., Zhang, J., & Wang, J. (2021) · Food & Function · doi:10.1039/d0fo03013a · Cited by 24
Insight into Analysis of Essential Oil from Anisosciadium lanatum Boiss.—Chemical Composition, Molecular Docking, and Mitigation of Hepg2 Cancer Cells through Apoptotic Markers
Khalil, H. E., Ibrahim, H.-I. M., Darrag, H. M., & Matsunami, K. (2021) · Plants · doi:10.3390/plants11010066 · Cited by 25
HDAC inhibitor chidamide synergizes with venetoclax to inhibit the growth of diffuse large B-cell lymphoma via down-regulation of MYC, BCL2, and TP53 expression
Luo, C., Yu, T., Young, K. H., & Yu, L. (2022) · Journal of Zhejiang University SCIENCE B · doi:10.1631/jzus.b2200016 · Cited by 24
MicroRNA‑9‑5p downregulates Klf4 and influences the progression of hepatocellular carcinoma via the AKT signaling pathway
Dong, X., Wang, F., Xue, Y., Lin, Z., Song, W., Yang, N., & Li, Q. (2019) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2019.4062 · Cited by 24
Interferon-Tau Exerts Direct Prosurvival and Antiapoptotic Actions in Luteinized Bovine Granulosa Cells
Basavaraja, R., Madusanka, S. T., Drum, J. N., Shrestha, K., Farberov, S., Wiltbank, M. C., Sartori, R., & Meidan, R. (2019) · Scientific Reports · doi:10.1038/s41598-019-51152-6 · Cited by 24
The role of Bax in the apoptosis of Leishmania-infected macrophages
Aghaei, M., Khanahmad, H., Aghaei, S., Nilforoushzadeh, M. A., Mohaghegh, M. A., & Hejazi, S. H. (2019) · Microbial Pathogenesis · doi:10.1016/j.micpath.2019.103892 · Cited by 24
Ethyl acetate extract of Caesalpinia sappan L. inhibited acute myeloid leukemia via ROS-mediated apoptosis and differentiation
Ma, H., Wang, C., He, H., Yu, Z., Tong, Y., Liu, G., Yang, Y., Li, L., Pang, L., & Qi, H. (2019) · Phytomedicine · doi:10.1016/j.phymed.2019.153142 · Cited by 24
Long non-coding RNA CRNDE promotes malignant progression of hepatocellular carcinoma through the miR-33a-5p/CDK6 axis
Lin, C., Xiang, Y., Sheng, J., Shui, L., Cui, M., & Zhang, X. (2020) · Journal of Physiology and Biochemistry · doi:10.1007/s13105-020-00754-0 · Cited by 24
Overcoming Resistance to AC0010, a Third Generation of EGFR Inhibitor, by Targeting c-MET and BCL-2
Xu, W., Tang, W., Li, T., Zhang, X., & Sun, Y. (2019) · Neoplasia · doi:10.1016/j.neo.2018.11.004 · Cited by 23
Genetic Modifiers of the Breast Tumor Microenvironment
Flister, M. J., & Bergom, C. R. (2018) · Trends in cancer · doi:10.1016/j.trecan.2018.04.003 · Cited by 24
Targeting RAS in pediatric cancer: is it becoming a reality?
Vaseva, A. V., & Yohe, M. E. (2019) · Current Opinion in Pediatrics · doi:10.1097/mop.0000000000000856 · Cited by 24
Venetoclax-based Rational Combinations are Effective in Models of MYCN -amplified Neuroblastoma
Dalton, K. M., Krytska, K., Lochmann, T. L., Sano, R., Casey, C. E., D'Aulerio, A., Khan, Q. A., Crowther, G. S., Coon, C. M., Cai, J., et al. (2021) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-20-0710 · Cited by 26
Self-citation
Senegenin Inhibits Aβ1-42-Induced PC12 Cells Apoptosis and Oxidative Stress via Activation of the PI3K/Akt Signaling Pathway
Ren, X., Zhang, J., Zhao, Y., & Sun, L. (2022) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s346238 · Cited by 22
Bcl‐2 family in non‐small cell lung cancer: its prognostic and therapeutic implications
Sun, P., Sasano, H., & Gao, H. (2017) · Pathology International · doi:10.1111/pin.12507 · Cited by 24
miR-516b functions as a tumor suppressor by directly modulating CCNG1 expression in esophageal squamous cell carcinoma
Zhao, Y., Wang, Y., & Xing, G. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.07.074 · Cited by 23
Capsaicin-like analogue induced selective apoptosis in A2058 melanoma cells: Design, synthesis and molecular modeling
Pereira, G. J. V., Tavares, M. T., Azevedo, R., Martins, B. B., Cunha, M. R., Bhardwaj, R., Cury, Y., Zambelli, V. O., Barbosa, E. G., Hediger, M. A., et al. (2019) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2019.05.020 · Cited by 23
Connecting Cancer Pathways to Tumor Engines: A Stratification Tool for Colorectal Cancer Combining Human In Vitro Tissue Models with Boolean In Silico Models
Baur, F., Nietzer, S., Kunz, M., Saal, F., Jeromin, J., Matschos, S., Linnebacher, M., Walles, H., Dandekar, T., & Dandekar, G. (2019) · Cancers · doi:10.3390/cancers12010028 · Cited by 23
Selective Covalent Targeting of Anti‐apoptotic BFL‐1 by a Sulfonium‐Tethered Peptide
Liu, N., Wang, D., Lian, C., Zhao, R., Tu, L., Zhang, Y., Liu, J., Zhu, H., Yu, M., Wan, C., et al. (2020) · ChemBioChem · doi:10.1002/cbic.202000473 · Cited by 23
Standardized Bacopa monnieri Extract Ameliorates Learning and Memory Impairments through Synaptic Protein, Neurogranin, Pro-and Mature BDNF Signaling, and HPA Axis in Prenatally Stressed Rat Offspring
Sivasangari, K., & Rajan, K. E. (2020) · Antioxidants · doi:10.3390/antiox9121229 · Cited by 24
Pre-therapeutic efficacy of the CDK inhibitor dinaciclib in medulloblastoma cells
Buzzetti, M., Morlando, S., Solomos, D., Mehmood, A., Cox, A. W. I., Chiesa, M., D’Alessandra, Y., Garofalo, M., Topham, C. H., & Leva, G. D. (2021) · Scientific Reports · doi:10.1038/s41598-021-84082-3 · Cited by 22
Noscapine and Apoptosis in Breast and Other Cancers
Calaf, G. M., Crispin, L. A., & Quisbert-Valenzuela, E. O. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25063536 · Cited by 22
A synthetic-lethality RNAi screen reveals an ERK-mTOR co-targeting pro-apoptotic switch in PIK3CA+ oral cancers
Yamaguchi, K., Iglesias‐Bartolomé, R., Wang, Z., Callejas‐Valera, J. L., Amornphimoltham, P., Molinolo, A., Cohen, E. E. W., Califano, J. A., Lippman, S. M., Luo, J., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.7372 · Cited by 22
Induction of Apoptosis by Citrus unshiu Peel in Human Breast Cancer MCF-7 Cells: Involvement of ROS-Dependent Activation of AMPK
Kim, M. Y., Bo, H. H., Choi, E. O., Kwon, D. H., Kim, H. J., Ahn, K. I., Ji, S. Y., Jeong, J., Park, S., Hong, S. H., et al. (2018) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b17-00898 · Cited by 22
Functional apoptosis profiling identifies MCL-1 and BCL-xL as prognostic markers and therapeutic targets in advanced thymomas and thymic carcinomas
Müller, D., Mazzeo, P., Koch, R., Bösherz, M.-S., Welter, S., von Hammerstein-Equord, A. F., Hinterthaner, M., Cordes, L., Belharazem, D., Marx, A., et al. (2021) · BMC Medicine · doi:10.1186/s12916-021-02158-3 · Cited by 20
Induction of apoptosis by ethanol extract of Citrus unshiu Markovich peel in human bladder cancer T24 cells through ROS-mediated inactivation of the PI3K/Akt pathway
Ahn, K. I., Choi, E. O., Kwon, D. H., Hwangbo, H., Kim, M. Y., Kim, H. J., Ji, S. Y., Hong, S. H., Jeong, J.-W., Park, C., et al. (2017) · BioScience Trends · doi:10.5582/bst.2017.01218 · Cited by 22
Targeting the BCL2 Family: Advances and Challenges in BH3 Mimetic-Based Therapies
Mukherjee, N., Sheetz, J., & Shellman, Y. G. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26209859 · Cited by 24
Antiproliferative effect of Moringa oleifera methanolic leaf extract by down-regulation of Notch signaling in DU145 prostate cancer cells
Khan, F., Pandey, P., Jha, N. K., Jafri, A., & Khan, I. M. (2020) · Gene Reports · doi:10.1016/j.genrep.2020.100619 · Cited by 21
A novel kinase inhibitor, LZT-106, downregulates Mcl-1 and sensitizes colorectal cancer cells to BH3 mimetic ABT-199 by targeting CDK9 and GSK-3β signaling
Yu, Z., Du, J., Zhao, Y., Gao, Y., Li, Y., Zhao, K., & Lu, N. (2020) · Cancer Letters · doi:10.1016/j.canlet.2020.10.001 · Cited by 21
Senegenin Inhibits Aβ1-42-Induced PC12 Cells Apoptosis and Oxidative Stress via Activation of the PI3K/Akt Signaling Pathway
Ren, X., Zhang, J., Zhao, Y., & Sun, L. (2022) · Dove Medical Press (Taylor and Francis Group) · Cited by 21
Microarray gene expression profiling in colorectal (HCT116) and hepatocellular (HepG2) carcinoma cell lines treated withMelicope ptelefolialeaf extract reveals transcriptome profiles exhibiting anticancer activity
Kabir, M. F., Ali, J. M., & Hashim, O. H. (2018) · PeerJ · doi:10.7717/peerj.5203 · Cited by 21
Cucurbitacin B induces mitochondrial-mediated apoptosis pathway in cholangiocarcinoma cells via suppressing focal adhesion kinase signaling
Klungsaeng, S., Kukongviriyapan, V., Prawan, A., Kongpetch, S., & Senggunprai, L. (2018) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-018-1584-3 · Cited by 21
Light-Induced Lipocalin 2 Facilitates Cellular Apoptosis by Positively Regulating Reactive Oxygen Species/Bim Signaling in Retinal Degeneration
Tang, W., Ma, J., Gu, R., Lei, B., Ding, X., & Xu, G. (2018) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.18-25213 · Cited by 21
microRNA‐23a contributes to asthma by targeting BCL2 in airway epithelial cells and CXCL12 in fibroblasts
Jin, A., Bao, R., Roth, M., Liu, L., Yang, X., Tang, X., Yang, X., Sun, Q., & Lu, S. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.28718 · Cited by 21
Inhibition of JAK2/STAT3 and activation of caspase‑9/3 are involved in KYS05090S‑induced apoptosis in ovarian cancer cells
Kim, B., Kim, J., Sim, D. Y., Nam, M., Jung, J. H., Shim, B., Lee, J. Y., & Kim, S. (2019) · International Journal of Oncology · doi:10.3892/ijo.2019.4795 · Cited by 20
Co‐targeting bromodomain and extra‐terminal proteins and MCL1 induces synergistic cell death in melanoma
Tseng, H., Dreyer, J., Emran, A. A., Gunatilake, D., Pirozyan, M. R., Cullinane, C. M., Dutton‐Regester, K., Rizos, H., Hayward, N. K., McArthur, G. A., et al. (2020) · International Journal of Cancer · doi:10.1002/ijc.33000 · Cited by 20
Chemosensitizing activity of peptide from Lentinus squarrosulus (Mont.) on cisplatin-induced apoptosis in human lung cancer cells
Khine, H. E. E., Ecoy, G. A. U., Roytrakul, S., Phaonakrop, N., Pornputtapong, N., Prompetchara, E., Pithi Chanvorachote, B., & Chaotham, C. (2021) · Scientific Reports · doi:10.1038/s41598-021-83606-1 · Cited by 20
Protective Effects of Cinnamaldehyde on the Oxidative Stress, Inflammatory Response, and Apoptosis in the Hepatocytes of Salmonella Gallinarum‐Challenged Young Chicks
Yin, L., Hussain, S., Tang, T., Gou, Y., He, C., Liang, X., Yin, Z., Shu, G., Zou, Y., Fu, H., et al. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/2459212 · Cited by 20
Macroporous silica nanoparticles for delivering Bcl2-function converting peptide to treat multidrug resistant-cancer cells
Xu, W., Ge, P., Niu, B., Zhang, X.-K., Liu, J., & Xie, J. (2018) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2018.05.033 · Cited by 20
Phyla nodiflora L. Extracts Induce Apoptosis and Cell Cycle Arrest in Human Breast Cancer Cell Line, MCF-7
Teoh, P. L., Liau, M., & Cheong, B. E. (2019) · Nutrition and Cancer · doi:10.1080/01635581.2018.1559942 · Cited by 20
Therapeutic considerations of PARP in stem cell biology: Relevance in cancer and beyond
Zeniou, M., Nguekeu-Zebaze, L., & Dantzer, F. (2019) · Biochemical Pharmacology · doi:10.1016/j.bcp.2019.06.012 · Cited by 22
Anticarcinogenic effect of zinc oxide nanoparticles synthesized from Rhizoma paridis saponins on Molt-4 leukemia cells
Xu, Z., Wu, Y., Song, L., Chinnathambi, A., Alharbi, S. A., & Fang, L. (2020) · Journal of King Saud University - Science · doi:10.1016/j.jksus.2020.01.023 · Cited by 20
Further lead optimization on Bax activators: Design, synthesis and pharmacological evaluation of 2-fluoro-fluorene derivatives for the treatment of breast cancer
Liu, G., Kim, H., Wang, P., Fricke, D. R., Chen, H., Wang, T., Shen, Q., & Zhou, J. (2021) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2021.113427 · Cited by 19
Pyrazine Moiety: Recent Developments in Cancer Treatment
Sahu, R., Shah, K., Gautam, Y., & Sahu, K. (2023) · Current Organic Chemistry · doi:10.2174/1385272827666230816105317 · Cited by 19
Deciphering resistance mechanisms and novel strategies to overcome drug resistance in ovarian cancer: a comprehensive review
Alemzadeh, E., Allahqoli, L., Mazidimoradi, A., Alemzadeh, E., Ghasemi, F., Salehiniya, H., & Alkatout, İ. (2024) · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics · doi:10.32604/or.2024.031006 · Cited by 19
Combination of dasatinib and venetoclax in newly diagnosed chronic phase chronic myeloid leukemia
Jabbour, E. J., Haddad, F., Sasaki, K., Carter, B. Z., Alvarado, Y., Nasnas, C. C., Nasr, L. F., Masárová, L., Daver, N. G., Pemmaraju, N., et al. (2024) · Cancer · doi:10.1002/cncr.35317 · Cited by 20
Combination Treatment with the BRAF V600E Inhibitor Vemurafenib and the BH3 Mimetic Navitoclax for BRAF -Mutant Thyroid Carcinoma
Jeong, J. H., Oh, J. M., Jeong, S. Y., Lee, S., Lee, J., & Ahn, B. (2019) · Thyroid · doi:10.1089/thy.2018.0511 · Cited by 19
Effect of maternal omega-3 fatty acids and vitamin E supplementation on placental apoptotic markers in rat model of early and late onset preeclampsia
Kasture, V., Kale, A. A., Randhir, K., Sundrani, D. P., & Joshi, S. (2019) · Life Sciences · doi:10.1016/j.lfs.2019.117038 · Cited by 19
Ovarian carcinoma immunoreactive antigen domain 2 controls mitochondrial apoptosis in lung adenocarcinoma
Hong, J., Shiba‐Ishii, A., Kim, Y., Noguchi, M., & Sakamoto, N. (2021) · Cancer Science · doi:10.1111/cas.15160 · Cited by 18
Dibenzylideneacetone Induces Apoptosis in Cervical Cancer Cells through Ros-Mediated Mitochondrial Damage
Zani, A. P., Zani, C. P., Din, Z. U., Filho, E. R., Ueda‐Nakamura, T., Garcia, F. P., Silva, S. D. O., & Nakamura, C. V. (2023) · Antioxidants · doi:10.3390/antiox12020317 · Cited by 18
Panobinostat sensitizes AraC-resistant AML cells to the combination of azacitidine and venetoclax
Zhao, J., Wu, S., Wang, D., Edwards, H. J., Thibodeau, J., Kim, S., Stemmer, P. M., Wang, G., Jin, J., Savaşan, S., et al. (2024) · Biochemical Pharmacology · doi:10.1016/j.bcp.2024.116065 · Cited by 18
Pachymic acid inhibits the tumorigenicity of gastric cancer cells by the mitochondrial pathway
Lu, C., Ma, J., & Cai, D. (2016) · Anti-Cancer Drugs · doi:10.1097/cad.0000000000000449 · Cited by 18
CD4+T Cell Subset Profiling in Biliary Atresia Reveals ICOS− Regulatory T Cells as a Favorable Prognostic Factor
Zhang, S., Goswami, S., Ma, J., Lu, M., Wang, Y., Zhu, F., Zhang, D., Zheng, S., Dong, R., Xiao, X., et al. (2019) · Frontiers in Pediatrics · doi:10.3389/fped.2019.00279 · Cited by 18

Authors: Hata, A. N., Engelman, J. A., & Faber, A. C.
Affiliations: Harvard University (US)
Virginia Commonwealth University (US)
Corresponding author: Engelman, Jeffrey A.
Faber, Anthony C.
ORCID: Hata, Aaron N.
Engelman, Jeffrey A.
Faber, Anthony C.
Venue: Cancer Discovery
Publisher: American Association for Cancer Research (AACR)
Published: 2015-05-01
Volume: 5
Issue: 5
Pages: 475-487
ISSN: 2159-8274 (ISSN-L)
2159-8290
DOI: 10.1158/2159-8290.cd-15-0011
PMC: PMC4727530
OpenAlex: W2067275727
Cited by: 619
References: 185
Citations by year: 2026: 19 · 2025: 48 · 2024: 46 · 2023: 42 · 2022: 69 · 2021: 79 · 2020: 83 · 2019: 79 · 2018: 73 · 2017: 45 · 2016: 29 · 2015: 6
FWCI: 4.94
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Locations: Cancer Discovery (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
Funders: National Cancer Institute (P50CA127003, R01CA140594, R01CA164273, R01CA137008)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Autophagy in Disease and Therapy
Keywords: Bcl-2 family proteins, apoptosis, targeted cancer therapy, mitochondrial apoptosis, cancer therapy response, carcinogenesis, apoptosis resistance
MeSH terms: Bcl-2-Like Protein 11, Animals, Antineoplastic Agents, Humans, Membrane Proteins, Neoplasms, Proto-Oncogene Proteins, Signal Transduction, Biomarkers, Apoptosis, Proto-Oncogene Proteins c-bcl-2, Apoptosis Regulatory Proteins, Molecular Targeted Therapy

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

The BCL2 Family: Key Mediators of the Apoptotic Response to Targeted Anticancer Therapeutics

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks